Psoriatic Arthritis Therapeutics Market - Global Industry Analysis
Psoriatic Arthritis Therapeutics Market by Drug Class (Interleukin Inhibitors, TNF Inhibitors, PDE4 Inhibitors, and Others), by Disease Type (Asymmetric Psoriatic Arthritis, Symmetric Psoriatic Arthritis, Distal Interphalangeal Predominant (DIP) Psoriatic Arthritis, Spondylitis, and Arthritis Mutilans), and by Distribution Channel (Hospital Pharmacies, Online Pharmacies, and Retail Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025
Published Date: 01-Jul-2019Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-4271
Status : Published
Global psoriatic arthritis therapeutics market expected to generate around USD 16.71 billion by 2025, at a CAGR of around 11.2% between 2019 and 2025. The global psoriatic arthritis therapeutics market is mainly driven by the increased prevalence of psoriasis that is leading to the rise in the number of psoriatic arthritis patients.